{"transactions":[{"id":968824,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-16T01:41:49.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":135883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended . The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year."}],"balance_after":135883,"derivative":{"exercise_price":0.325,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":135883},"source":{"system":"sec-edgar","filing":"0001493152-25-027834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225027834/ownership.xml","form_type":"4"}},{"id":1318247,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-02T21:05:22.000Z","date":"2024-12-31","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":2.94,"value":10290.0,"ownership":{"direct":true},"balance_after":11155,"source":{"system":"sec-edgar","filing":"0001493152-25-000058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225000058/ownership.xml","form_type":"4"}},{"id":1323810,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-21T01:33:15.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":19752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year."}],"balance_after":19752,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":19752},"source":{"system":"sec-edgar","filing":"0001493152-24-051147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315224051147/ownership.xml","form_type":"4"}},{"id":1718830,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-07T22:05:57.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":13856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year."}],"balance_after":13856,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":13856},"source":{"system":"sec-edgar","filing":"0001493152-23-044058","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315223044058/ownership.xml","form_type":"4"}},{"id":2097742,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-02T21:30:31.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":8403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year."}],"balance_after":8403,"derivative":{"exercise_price":6.7,"expiration_date":"2032-11-30","underlying":"Common Stock","underlying_shares":8403},"source":{"system":"sec-edgar","filing":"0001493152-22-034315","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222034315/ownership.xml","form_type":"4"}},{"id":2156915,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-16T20:05:22.000Z","date":"2022-09-13","kind":"exercise","acquired":false,"shares":1041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of enVVeno Medical Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1041},"source":{"system":"sec-edgar","filing":"0001493152-22-026071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222026071/ownership.xml","form_type":"4"}},{"id":2156914,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T20:05:22.000Z","date":"2022-09-13","kind":"exercise","acquired":true,"shares":1041,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of enVVeno Medical Corporation."}],"balance_after":7655,"source":{"system":"sec-edgar","filing":"0001493152-22-026071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222026071/ownership.xml","form_type":"4"}},{"id":2488065,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-02T21:05:50.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":7211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2022 calendar year."}],"balance_after":7211,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":7211},"source":{"system":"sec-edgar","filing":"0001493152-21-030305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221030305/ownership.xml","form_type":"4"}},{"id":2568645,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-09-16T01:50:12.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of Hancock Jaffe Laboratories, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on September 26, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on September 26, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021."}],"balance_after":2084,"derivative":{"underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001493152-21-022862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221022862/ownership.xml","form_type":"4"}},{"id":2568644,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-16T01:50:12.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":1042,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of Hancock Jaffe Laboratories, Inc."}],"balance_after":6614,"source":{"system":"sec-edgar","filing":"0001493152-21-022862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221022862/ownership.xml","form_type":"4"}},{"id":2659912,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T23:16:28.000Z","date":"2021-06-16","kind":"purchase","acquired":true,"shares":2000,"price":6.25,"value":12500.0,"ownership":{"direct":true},"balance_after":5572,"source":{"system":"sec-edgar","filing":"0001493152-21-014906","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221014906/ownership.xml","form_type":"4"}},{"id":2842623,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-02-23T02:56:48.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":5673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the reporting person as part of the annual board compensation package for 2021. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2021 calendar year."}],"balance_after":5673,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":5673},"source":{"system":"sec-edgar","filing":"0001493152-21-004529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221004529/ownership.xml","form_type":"4"}},{"id":3078518,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-07-22T01:56:08.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted as part of the annual board compensation package for 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the Reporting Person on July 18, 2020. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the calendar year. Any non-exercisable portion of the Option will immediately vest and become exercisable in the event that the grantees employment is terminated other than Cause (as defined in the \"Employment Agreement\") within 3 years of Change of Control as defined in the Plan."}],"balance_after":100000,"derivative":{"exercise_price":0.4,"expiration_date":"2030-07-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-013752","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220013752/ownership.xml","form_type":"4"}},{"id":3078517,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-22T01:56:08.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted as part of the annual board compensation package for 2020."}],"balance_after":78250,"source":{"system":"sec-edgar","filing":"0001493152-20-013752","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220013752/ownership.xml","form_type":"4"}},{"id":3405663,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-26T20:30:18.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The common stock options were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from September 13, 2019."}],"balance_after":60000,"derivative":{"exercise_price":2,"expiration_date":"2029-09-13","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001493152-19-014616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315219014616/ownership.xml","form_type":"4"}},{"id":3405662,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-09-26T20:30:18.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":78125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each Restricted Stock Unit (\"RSU\") entitles the Reporting Person to one share of the Issuer's common stock or the cash equivalent, at the discretion of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the \"Plan\"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) September 13, 2020; (ii) September 13, 2021; and (iii) September 13, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the \"Plan\"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) September 13, 2020; (ii) September 13, 2021; and (iii) September 13, 2022."}],"balance_after":78125,"derivative":{"underlying":"Common Stock","underlying_shares":78125},"source":{"system":"sec-edgar","filing":"0001493152-19-014616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315219014616/ownership.xml","form_type":"4"}}]}